Home > News > IBN seeks venture capitalists
May 13th, 2005
IBN seeks venture capitalists
The Institute of Bioengineering and Nanotechnology (IBN) is looking for venture capitalists for a yet-to-be-named company that will deal in molecular diagnostics.
The IBN's executive director Prof Jackie Ying revealed the spin-off at the institute's official opening yesterday — exactly one year after it moved into the Biopolis.
Institute of Bioengineering and Nanotechnology
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Champions Oncology, Inc. April 17th, 2014
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
MRI, on a molecular scale: Researchers develop system that could one day peer into the atomic structure of individual molecules April 20th, 2014
Iranian Researchers Present New Model to Strengthen Superconductivity at Higher Temperatures April 19th, 2014
Iranian Researchers Produce New Anti-Cancer Drug from Turmeric April 19th, 2014
Innovative strategy to facilitate organ repair April 18th, 2014